In 2022, the United States experienced a severe shortage of infant formula as a result of the 2021–2022 global supply chain crisis compounded by a large scale product recall after two babies allegedly died after consuming Abbott infant formula,[1][2]import restrictions,[3] and market concentration.[4] Unlike other food products, infant formula often does not have an available and acceptable substitute as a source of nutrition for those who rely on it.[5][6] In addition to infants, the formula recalls have affected non-infant medical patients who require nasogastric feeding[6][7] or have certain other conditions.[8][9][10] Bare formula shelves with purchase limit notice, at a Safeway store in Monroe, Washington, in January 2022
As of May 14, nationwide out-of-stock rates were reported to be 43%, up from 31% two weeks prior; by May 22, they had surged to 70%.[11]The Wall Street Journal states that the normal out-of-stock rate is 10%,[12] while other sources say that in the first half of 2021, out-of-stock rates were 2%-8%.[13]) In many places, store shelves are bare. Delaware, Kansas, and Tennessee were the hardest-hit states.[12] As of mid-May, manufacturers and retailers expected a months-long delay before formula stocks would be fully restored.[14] On May 27, FDA Commissioner Robert Califf reported to the Senate Health Committee that shortages would continue into July.[15] Effects of the shortage have also been felt in Canada.[16]
BUB Price at posting:
62.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)